A PhD student at the University of Kentucky, Sherif El-Refai focuses on pharmaceutical science, specifically as it relates to oncology. Sherif El-Refai also participates in university’s Black Lab.
Propelling cancer research, the Black Lab consists of students studying gene expression and how to manipulate it so individuals receiving therapies have a higher potential of successfully combating the disease. The team has access to patient tumor samples, cancer cell lines, and bioinformatic data to develop wet-lab experiments.
Since its inception, the Black Lab has produced in excess of 15 publications on topics ranging from the deregulation of DUSP activity in EGFR-mutant lung cancer cell lines to gene expression signatures on cancer drug discovery. The works appear in such periodicals a Future Oncology, the European Pharmaceutical Review, and Clinical Medicine Reviews in Oncology.
More recently, the lab shared corporate communication strategies for teaching non-science communication skills to pharmaceutical sciences PhD students in Currents in Pharmacy Teaching and Learning.